Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
2
×
boston top stories
clinical trials
life sciences
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
2
×
san francisco top stories
amgen
arena pharmaceuticals
biotech
boulder/denver blog main
boulder/denver top stories
cancer
cardiovascular disease
cholesterol
colorectal cancer
data
detroit blog main
detroit top stories
eisai
europe blog main
europe top stories
fda
inclisiran
indiana blog main
indiana top stories
ldl
lorcaserin
lung cancer
mark timney
mt sinai hospital
national
new york
obsesity
orexigen therapeutics
pancreatic cancer
pcsk9
What
drug
2
×
medicine
2
×
aces
announced
big
cancer
ceo
cholesterol
eisai
fda
flags
flexible
higher
incidence
inclisiran
key
lorcaserin
loss
lowering
market
marketing
meant
medco
medicines
nasdaq
open
passed
patients
post
pricing
pulls
risks
study
taken
test
took
twice
week
weight
withdrawing
Language
unset
2
×
Current search:
drug
×
unset
×
" san francisco blog main "
×
" boston blog main "
×
medicine
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
